A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis

NCT01356940 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDIV

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: dalfampridine ER
DRUG: placebo

Sponsor

Brown, Theodore R., M.D., MPH

Collaborators

[object Object]